As of 2026-04-06, the Intrinsic Value of Shilpa Medicare Ltd (SHILPAMED.NS) is 727.95 INR. This SHILPAMED.NS valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 388.90 INR, the upside of Shilpa Medicare Ltd is 87.20%.
The range of the Intrinsic Value is 641.73 - 831.41 INR
Based on its market price of 388.90 INR and our intrinsic valuation, Shilpa Medicare Ltd (SHILPAMED.NS) is undervalued by 87.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (1,229.79) - (775.06) | (946.51) | -343.4% |
| DCF (Growth 10y) | (663.78) - (948.15) | (772.96) | -298.8% |
| DCF (EBITDA 5y) | 641.73 - 831.41 | 727.95 | 87.2% |
| DCF (EBITDA 10y) | 1,605.04 - 2,318.42 | 1,923.47 | 394.6% |
| Fair Value | 191.79 - 191.79 | 191.79 | -50.68% |
| P/E | 104.06 - 169.55 | 141.89 | -63.5% |
| EV/EBITDA | 202.86 - 242.29 | 221.36 | -43.1% |
| EPV | (41.38) - (43.96) | (42.67) | -111.0% |
| DDM - Stable | 44.20 - 93.27 | 68.74 | -82.3% |
| DDM - Multi | 273.70 - 451.13 | 340.95 | -12.3% |
| Market Cap (mil) | 76,061.06 |
| Beta | 0.63 |
| Outstanding shares (mil) | 195.58 |
| Enterprise Value (mil) | 81,773.95 |
| Market risk premium | 8.31% |
| Cost of Equity | 13.78% |
| Cost of Debt | 8.18% |
| WACC | 13.17% |